Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer
This study is ongoing, but not recruiting participants.
Study NCT00006225 Information provided by National Cancer Institute (NCI)
First Received: September 11, 2000 Last Updated: February 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Leukemia
Lymphoma
Additional conditions recognized in this trial
Breast Neoplasms
Lymphoma, Large-Cell, Immunoblastic
Lymphoma, Non-Hodgkin
Multiple Myeloma
Myelodysplastic-Myeloproliferative Diseases
Myeloproliferative Disorders
Neoplasms
Neoplasms, Plasma Cell
More general conditions related to this trial
Blood Protein Disorders
Bone Marrow Diseases
Breast Diseases
Cardiovascular Diseases
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Neoplasms by Site
Paraproteinemias
Skin Diseases
Vascular Diseases
Interventions listed in this trial
filgrastim
recombinant flt3 ligand
recombinant human thrombopoietin
recombinant interleukin-3
Additional drug interventions recognized in this trial
Flt3 ligand protein
More general drug interventions related to this trial
Adjuvants, Immunologic
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Radiation-Protective Agents
Sponsors listed in this trial
Robert H. Lurie Cancer Center
Back to top of Main Content
